tbResList Print — statins statins

Filters: qv=18, qv2=%, rfv=%

Product

statins statins
Description: <b>Statins</b>, inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, which act downstream of ACL in the cholesterol synthesis pathway, can dramatically enhance the anti-tumor effects of ACL inhibition.<br>

Pathway results for Effect on Cancer / Diseased Cells

Redox & Oxidative Stress(tgid=1) ⓘ

ROS↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

p‑ACLY↓, 1,   HMG-CoA↓, 1,  

Cell Death(tgid=5) ⓘ

p‑Akt↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

EMT↓, 1,  

Migration(tgid=13) ⓘ

E-cadherin↑, 1,   MUC1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

EGFR↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

eff↑, 4,  

Clinical Biomarkers(tgid=22) ⓘ

EGFR↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiTum↑, 1,  
Total Targets: 11

Pathway results for Effect on Normal Cells

NA, unassigned(tgid=0) ⓘ

TMAO↓, 4,  

Drug Metabolism & Resistance(tgid=21) ⓘ

eff↝, 1,  
Total Targets: 2

Research papers

Year Title Authors PMID Link Flag
2023An Update on Impacts of Epigallocatechin Gallate Co-administration in Modulating Pharmacokinetics of Statins, Calcium Channel Blockers, and Beta-blockersLee Siew-Keah37328148https://pubmed.ncbi.nlm.nih.gov/37328148/0
2025Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human HealthEugenio CaradonnaPMC12029716https://pmc.ncbi.nlm.nih.gov/articles/PMC12029716/0
2013Inhibition of Lung Cancer Growth: ATP Citrate Lyase Knockdown and Statin Treatment Leads to Dual Blockade of Mitogen-Activated Protein Kinase (MAPK) and Phosphatidylinositol-3-Kinase (PI3K)/AKT PathwaysJUN-ICHI HANAIPMC3407542https://pmc.ncbi.nlm.nih.gov/articles/PMC3407542/0